Mayinglong Pharmaceutical Group Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is -9.32% vs 1.14% in Jun 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 9.91% vs -29.86% in Jun 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "881.30",
          "val2": "971.90",
          "chgp": "-9.32%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "164.70",
          "val2": "175.40",
          "chgp": "-6.10%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.70",
          "val2": "2.20",
          "chgp": "-22.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.20",
          "val2": "9.40",
          "chgp": "-112.77%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "161.90",
          "val2": "147.30",
          "chgp": "9.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "186.90%",
          "val2": "155.50%",
          "chgp": "3.14%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 18.93% vs -11.23% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 21.36% vs -5.76% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,701.70",
          "val2": "3,112.40",
          "chgp": "18.93%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "674.70",
          "val2": "471.20",
          "chgp": "43.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "15.00",
          "val2": "20.20",
          "chgp": "-25.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-11.80",
          "val2": "-0.30",
          "chgp": "-3,833.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "548.30",
          "val2": "451.80",
          "chgp": "21.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "158.90%",
          "val2": "122.50%",
          "chgp": "3.64%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ

Sep'25

Jun'25

Change(%)

Net Sales

881.30

971.90

-9.32%

Operating Profit (PBDIT) excl Other Income

164.70

175.40

-6.10%

Interest

1.70

2.20

-22.73%

Exceptional Items

-1.20

9.40

-112.77%

Consolidate Net Profit

161.90

147.30

9.91%

Operating Profit Margin (Excl OI)

186.90%

155.50%

3.14%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Sep 2025 is -9.32% vs 1.14% in Jun 2025

Consolidated Net Profit

QoQ Growth in quarter ended Sep 2025 is 9.91% vs -29.86% in Jun 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

3,701.70

3,112.40

18.93%

Operating Profit (PBDIT) excl Other Income

674.70

471.20

43.19%

Interest

15.00

20.20

-25.74%

Exceptional Items

-11.80

-0.30

-3,833.33%

Consolidate Net Profit

548.30

451.80

21.36%

Operating Profit Margin (Excl OI)

158.90%

122.50%

3.64%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 18.93% vs -11.23% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 21.36% vs -5.76% in Dec 2023

All Annual Results